Beleaguered blood diagnostics startup Theranos has reached a settlement with hedge fund management firm Partner Fund Management. PFM invested $96.1 million in Theranos’ Series C-2 round in 2014, helping to pop the company up to a $9 billion valuation. However, the hedge fund opened a lawsuit against Theranos last year saying the company had tricked it into investing “through a… Read More
via Tech Republiq
Monday, May 1, 2017
TechCrunch
Theranos reaches settlement with investor Partner Fund Management
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment